A forum for researchers, students and applicants in the field of cyclodextrin technology
Using MD simulations, the possible role of SBE-β-CDs aggregates in the solubilization of remdesivir was studied. Both the effect of
Aequus Pharmaceuticals Inc. and reVision Therapeutics, Inc. (“reVision”) announced a collaboration on the development of a therapy for Stargardt disease.
The work of Kulkarni and Belgamvar [1] demonstrates the impact of sulfobutyl ether-β-cyclodextrin (SBE-β-CD) complexation on the solubility, dissolution and
